Puritan 3 inch swabs

17th February 2020  Editorial by: Paul Carton

Thermo Fisher Partner up to Develop Nanotech Clinical Assays 

Thermo Fisher Scientific and NanoPin Technologies have partnered up to develop sensitive clinical assays for infectious diseases. NanoPin has proprietary antibody-conjugated nanoparticles which are specifically adapted to antigen peptides that are only present in the bloodstream when the targeted disease is active. NanoPin will advance their blood-based infectious disease detection technology by using Thermo Fisher's advanced liquid chromatography-mass spectrometry technology. 

This will enable healthcare providers to reduce time to results, determine infection stage and monitor patient response to prescribed treatment. The quantified information gleaned from the combined technology will support clinical decision-making and the provision of personalized patient care unique to their disease state.



Date Published: 17th February 2020

Source article link: View

View full company details

Picus 2 Pipette

bioMerieux European Dairy Quality Conference

Cherwell Are you ready for Annex 1 guide

Interscience ScanStation automatic colony counting

Pharma Microbiology Congress 2023

Get our eNewsletter
Over 7,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!